Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiomyocyte Apoptosis Following Antegrade and Retrograde Cardioplegia

NCT01185912 is registered in ClinicalTrials.gov with Turku University Hospital as lead sponsor.

NCT NCT01185912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01185912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiomyocyte Apoptosis Following Antegrade and Retrograde Cardioplegia
Lead sponsor
Turku University Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 2008
Completion date
January 31, 2010
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiomyocyte apoptosis